Science University Research Symposium (SURS)
Development of an HPLC Method for Quantifying Gemcitabine Loading in Folic Acid Carbon Dots
Publication Date
Fall 11-9-2026
College
College of Sciences & Mathematics
Department
Chemistry and Physics, Department of
SURS Faculty Advisor
Dr. Hua Mei
Presentation Type
Poster Presentation
Abstract
This research looks at the development and characterization of folic acid carbon dots (FACDs) as potential carriers of the chemotherapy drug gemcitabine (GEM). Folic acid serves as a targeting molecule because folate receptors are overexpressed in some cancer cells, potentially allowing for a more selective drug delivery. The nanoparticles are characterized using UV-VIS spectroscopy and fluorescence spectroscopy. However, the UV absorbance of folic acid and gemcitabine overlaps which brings a challenge in accurately quantifying drug loading using UV-VIS spectroscopy. A high-performance liquid chromatography (HPLC) method was developed to quantify gemcitabine loading in the nanoparticles. This method is being evaluated to determine drug loading capacity and drug loading efficiency. Additional experiments are underway to validate the accuracy of the HPLC method and develop an additional UV-visible spectroscopic method for comparison. This research aims to establish reliable methods for quantifying gemcitabine loading in folic acid carbon dots for potential applications in targeted cancer drug delivery.
Recommended Citation
Teclesenbet, Raymok and Mei, Hua Ph.D., "Development of an HPLC Method for Quantifying Gemcitabine Loading in Folic Acid Carbon Dots" (2026). Science University Research Symposium (SURS). 388.
https://repository.belmont.edu/surs/388
